2 reports of this reaction
1.8% of all CHLOROXYLENOL reports
#5 most reported adverse reaction
METASTASES TO LIVER is the #5 most commonly reported adverse reaction for CHLOROXYLENOL. There are 2 FDA adverse event reports linking CHLOROXYLENOL to METASTASES TO LIVER. This represents approximately 1.8% of all 109 adverse event reports for this drug.
Patients taking CHLOROXYLENOL who experience metastases to liver should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
METASTASES TO LIVER is a less commonly reported adverse event for CHLOROXYLENOL, but still significant enough to appear in the safety profile.
In addition to metastases to liver, the following adverse reactions have been reported for CHLOROXYLENOL:
The following drugs have also been linked to metastases to liver in FDA adverse event reports:
METASTASES TO LIVER has been reported as an adverse event in 2 FDA reports for CHLOROXYLENOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
METASTASES TO LIVER accounts for approximately 1.8% of all adverse event reports for CHLOROXYLENOL, making it a notable side effect.
If you experience metastases to liver while taking CHLOROXYLENOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.